Description
BSE announces the forthcoming listing and admission of equity shares of Sudeep Pharma Limited with scrip code 544619 and symbol SUDEEPPHRM.
Summary
BSE has informed trading members that equity shares of Sudeep Pharma Limited will be listed and admitted to dealings on the exchange in due course. The company has been assigned scrip code 544619, symbol SUDEEPPHRM, and ISIN number INE0QPI01025. The exact listing date and complete security details will be communicated through a separate notice.
Key Points
- Company Name: Sudeep Pharma Limited
- Scrip Code: 544619
- Symbol: SUDEEPPHRM
- ISIN Number: INE0QPI01025
- Listing will occur in due course with details to follow
- Trading members have been notified
Regulatory Changes
No regulatory changes announced. This is a standard new listing notification.
Compliance Requirements
Trading members should note the assigned scrip code and symbol for Sudeep Pharma Limited. No immediate action required until the formal listing date is announced.
Important Dates
- Notice Date: November 27, 2025
- Listing Date: To be announced through separate notice
- Security Details: To be provided in subsequent communication
Impact Assessment
This is a routine listing announcement with minimal immediate market impact. The notification serves to inform trading members of the forthcoming addition of Sudeep Pharma Limited to the BSE equity segment. Actual trading will commence only after the listing date is formally announced through a separate notice containing complete security details.
Impact Justification
Routine new listing announcement with specific date to be notified separately; limited immediate market impact